🇺🇸 FDA
Pipeline program

VX-880 solution for infusion

VX20-880-101

Phase 3 small_molecule active

Quick answer

VX-880 solution for infusion for Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Severe Hypoglycemia is a Phase 3 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Vertex Pharmaceuticals (Ireland) Limited
Indication
Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Severe Hypoglycemia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials